Thomas E. Stinchcombe

13.5k citations
238 papers · 10.3k · 6 hit papers · h-index 46

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 98
    • Lung Cancer Diagnosis and Treatment 92
    • Cancer Immunotherapy and Biomarkers 27
    • Lung Cancer Research Studies 21
    • Cancer Treatment and Pharmacology 5

Thomas E. Stinchcombe

227 papers receiving 10k citations

Thomas E. Stinchcombe's Hit Papers

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer 2023 · 634 citations
6340+3+7Years since publication4008001.2k

Peers

Thomas E. Stinchcombe
Comparison fields: 5 of 114
  • Pulmonary and Respiratory Medicine 4.7k
  • Oncology 2.8k
  • Radiation 342
  • Cancer Research 407
  • Geriatrics and Gerontology 99
Replace Frédéric Rolland with:
Frédéric Rolland France
Thierry Le Chevalier France
Lei Feng United States
Bonnie S. Glisson United States
Élisabeth Quoix France
Alberto Chiappori United States
Rogério Lilenbaum United States
Axel Hinke Germany
Denis Soulières Canada
Sylvie Rottey Belgium
Thomas E. Stinchcombe relative to Frédéric Rolland France Frédéric Rolland's profile →
Citations per field
00.5×2×3.0×
Frédéric Rolland · 1×
Citations per year

Countries citing papers authored by Thomas E. Stinchcombe

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Stinchcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Stinchcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Stinchcombe more than expected).

Fields of papers citing papers by Thomas E. Stinchcombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Stinchcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Stinchcombe. The network helps show where Thomas E. Stinchcombe may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas E. Stinchcombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas E. Stinchcombe Line = papers co-authored together Thomas E. Stinchcombe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Hit paper breakdown →
20151243
2
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Hit paper breakdown →
2023634
3 2002625
4
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Hit paper breakdown →
2017512
5
Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy
Hit paper breakdown →
2017350
6 2007297
7
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
Hit paper breakdown →
2018279
8 2010211
9 2013208
10 2018205
11 2012196
12 2019186
13 2007183
14 2011162
15 2013159
16 2012146
17 2016134
18 2019134
19 2009121
20 2007105

About Thomas E. Stinchcombe

Thomas E. Stinchcombe is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Statistics and Probability, Radiation and Genetics, having authored 238 papers that have together received 10.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (98 papers), Lung Cancer Diagnosis and Treatment (92 papers), Cancer Immunotherapy and Biomarkers (27 papers), Lung Cancer Research Studies (21 papers), Statistical Methods in Clinical Trials (7 papers), Genetic Associations and Epidemiology (6 papers), Ethics in Clinical Research (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Oncology (2.8k citations), Radiation (342 citations), Cancer Research (407 citations) and Geriatrics and Gerontology (99 citations). Thomas E. Stinchcombe has collaborated with scholars based in United States, Canada and Hong Kong. Frequent co-authors include Mark A. Socinski, Patrick J. Roberts, Carrie B. Lee, Everett E. Vokes, Dominic T. Moore, Vinicius Ernani, Xiaofei Wang, Julian G Rosenman, Karen L. Kelly and Channing J. Der. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer, Clinical Lung Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact